KEY PRODUCTS
Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
01 1LUNDBECK PHARMS LLC
02 1ACROTECH BIOPHARMA
03 2LUPIN
04 1MELINTA
05 1MERCK SHARP DOHME
06 1SAGE THERAP
01 78410077
01 7Blank
01 7Y
01 72029-03-13
Lundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.
Patent Expiration Date : 2029-03-13
US Patent Number : 8410077
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206030
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-13
Patent Expiration Date : 2029-03-13
US Patent Number : 8410077
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 207155
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-13
Patent Expiration Date : 2029-03-13
US Patent Number : 8410077
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210864
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-13
Patent Expiration Date : 2029-03-13
US Patent Number : 8410077
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210864
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-13
Patent Expiration Date : 2029-03-13
US Patent Number : 8410077
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 208611
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-13
Patent Expiration Date : 2029-03-13
US Patent Number : 8410077
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205596
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-13
Patent Expiration Date : 2029-03-13
US Patent Number : 8410077
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 211371
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-03-13
